Ilan Sobel, CEO of Israeli/Canadian biotech innovator BioHarvest Sciences, believes his company has developed a better way to grow major and minor cannabinoids. BioHarvest has developed a patented bio-cell growth platform technology capable of growing the active and beneficial ingredients in fruit and plants, at industrial scale, without the need to grow the plant itself. This technology is economical, ensures consistency, and avoids the negative environmental impacts associated with traditional agriculture. BioHarvest is currently focused on nutraceuticals and the medicinal cannabis markets.
The company, listed on the Canadian Securities Exchange, is considered a global leader in plant cell biology, having successfully brought to market VINIA®️, a proprietary red grape cell product containing the entire matrix of polyphenols contained in red grapes (polyphenols have been scientifically validated to provide significant health benefits). Ilan’s strategy is to apply this proven approach — leveraging the company’s technical expertise, e-commerce platform, and customer base — to address the hemp, medical and adult-use cannabis verticals.
Listen in as Ilan outlines BioHarvest’s three-pronged approach to disrupting the international cannabis marketplace, and engages with MJNews host David Rheins in an in-depth and provocative discussion of the future of biofarming cannabis, his deal with Royal Emerald Pharmaceuticals, and how the evolving FDA/DEA policy on cannabis research has opened up new business opportunities.
Be sure to stay tuned to the end — as Ilan provides some key insights for sector investors.
Thank you for turning on and tuning in. We hope that you enjoyed this Marijuana Channel One video exclusive. If so, we humbly ask that you Like, Share and Subscribe.
Marijuana Channel One is a creation of MJBA Publishing LLC. @2022 All rights are reserved. For more information, contact us at: email@example.com #mjnews #MJChannelOne.
BE HERE NOW